Therapeutic potential and challenges of mesenchymal stem cells in neurological disorders: A concise analysis.

IF 3 3区 医学 Q2 CLINICAL NEUROLOGY
Enas H Bani Issa, Enas M Alghazo, Raghad Gharaibeh, Noor B Momani, Dana Z Taha, Renad J Jaradat, Ayman Alzu'bi, Fatimah A Almahasneh, Ejlal Abu-El-Rub, Raed M Al-Zoubi
{"title":"Therapeutic potential and challenges of mesenchymal stem cells in neurological disorders: A concise analysis.","authors":"Enas H Bani Issa, Enas M Alghazo, Raghad Gharaibeh, Noor B Momani, Dana Z Taha, Renad J Jaradat, Ayman Alzu'bi, Fatimah A Almahasneh, Ejlal Abu-El-Rub, Raed M Al-Zoubi","doi":"10.1093/jnen/nlaf021","DOIUrl":null,"url":null,"abstract":"<p><p>Neurological diseases comprise a wide array of conditions affecting both the central and peripheral nervous systems. Neurodegenerative diseases encompass a group of debilitating and often fatal neurological disorders for which effective treatments are currently lacking. Stem cells are recognized for their remarkable capacity for proliferation, multilineage differentiation, and self-renewal. The transplantation of stem cells represents a significant advancement in therapeutic strategies for neurological disorders, with applications in both preclinical and clinical settings. Mesenchymal stem cells (MSCs), in particular, have garnered substantial interest due to their unique properties, making them a highly sought-after source of therapeutic cells. Although the efficacy of MSCs in treating neurological disorders is well documented, further research is needed to elucidate the underlying mechanisms and to assess their in vivo applications more comprehensively. This article summarizes current research on the use of MSCs in the treatment of various neurological disorders, including Parkinson disease, stroke, multiple sclerosis, and Alzheimer disease.</p>","PeriodicalId":16682,"journal":{"name":"Journal of Neuropathology and Experimental Neurology","volume":" ","pages":"668-679"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277701/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuropathology and Experimental Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jnen/nlaf021","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Neurological diseases comprise a wide array of conditions affecting both the central and peripheral nervous systems. Neurodegenerative diseases encompass a group of debilitating and often fatal neurological disorders for which effective treatments are currently lacking. Stem cells are recognized for their remarkable capacity for proliferation, multilineage differentiation, and self-renewal. The transplantation of stem cells represents a significant advancement in therapeutic strategies for neurological disorders, with applications in both preclinical and clinical settings. Mesenchymal stem cells (MSCs), in particular, have garnered substantial interest due to their unique properties, making them a highly sought-after source of therapeutic cells. Although the efficacy of MSCs in treating neurological disorders is well documented, further research is needed to elucidate the underlying mechanisms and to assess their in vivo applications more comprehensively. This article summarizes current research on the use of MSCs in the treatment of various neurological disorders, including Parkinson disease, stroke, multiple sclerosis, and Alzheimer disease.

间充质干细胞治疗神经系统疾病的潜力和挑战:简明分析。
神经系统疾病包括一系列影响中枢和周围神经系统的疾病。神经退行性疾病包括一组使人衰弱,往往是致命的神经系统疾病,目前缺乏有效的治疗方法。干细胞被认为具有显著的增殖能力、多系分化能力和自我更新能力。干细胞移植代表了神经系统疾病治疗策略的重大进步,在临床前和临床环境中都有应用。特别是间充质干细胞(MSCs),由于其独特的性质,使其成为备受追捧的治疗细胞来源,已经获得了大量的兴趣。虽然间充质干细胞治疗神经系统疾病的疗效已被充分证实,但还需要进一步的研究来阐明其潜在机制并更全面地评估其在体内的应用。本文综述了MSCs在治疗各种神经系统疾病方面的研究进展,包括帕金森病、中风、多发性硬化症和阿尔茨海默病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.40
自引率
6.20%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Journal of Neuropathology & Experimental Neurology is the official journal of the American Association of Neuropathologists, Inc. (AANP). The journal publishes peer-reviewed studies on neuropathology and experimental neuroscience, book reviews, letters, and Association news, covering a broad spectrum of fields in basic neuroscience with an emphasis on human neurological diseases. It is written by and for neuropathologists, neurologists, neurosurgeons, pathologists, psychiatrists, and basic neuroscientists from around the world. Publication has been continuous since 1942.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信